Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to ...
Atos SE (OTCMKTS:AEXAY – Get Free Report) saw a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 10,300 shares, a drop of 37.2% from the ...
Results that may be inaccessible to you are currently showing.